Indeed, in our previous studies, we identified a secretory signature associated with mutant p53 and KRAS-harboring cancer cells, which we dubbed the cancer-related gene signature (CGS) (Buganim et al., 2010; Solomon et al., 2012). The gene discussed is KRAS; the disease is cancer.